Annual Report 2019

20 Sunny Optical Technology (Group) Company Limited • ANNUAL REPORT 2019 Management Discussion and Analysis 管理層討論與分析 OPTICAL INSTRUMENTS During the year, the market demand for optical instruments was weak. The revenue of the Optical Instruments business segment amounted to approximately RMB284.9 million, representing an decrease of approximately 5.0% compared to that of last year. This business segment accounted for approximately 0.7% of the Group’s total revenue, compared to approximately 1.2% of last year. In the microscopes business, the Group completed the R&D of laser confocal scanning microscope. The field of view and imaging speed of the microscope are in the domestic leading position. Flexible switches can enable high-precision scanning and high-speed scanning which provides better hardware support for scientific researchers. At the same time, in the field of medical automated scanning, the Group pioneered and mass produced the first domestic 60-time apochromatic oil-immersion objective with a numerical aperture of 1.4. This objective can significantly enhance the coverage area with guaranteed distinguishability so as to improve the scanning efficiency. In the intelligent equipment business, the Group completed the R&D and batch sales of the pathological section scanner and has obtained certification from the China Food and Drug Administration. The scanner applies the technologies such as triple-prism micro-optical imaging, flight focus technology and ultra-depth of field to quickly form clear and high-level color rendition digital images of pathological sections, which in turn assist doctors in diagnosis and facilitate remote pathology and digital pathology storage. In addition, in the industrial field, the Group continued to increase the R&D investments in online optical inspection equipment and optimize the efficiency and performance of the equipment. As at 31 December 2019, a total of 147 granted patents have been obtained by the Group in the Optical Instruments business segment, including 21 invention patents, 100 utility model patents and 26 exterior design patents. In addition, 72 patents are pending for approval. 光學儀器 於年內，光學儀器的市場需求疲弱。光學儀器 事業的收入約人民幣 284,900,000 元，較去年 下降約 5.0% 。此業務部門佔本集團的總收入約 0.7% ，而在去年則佔約 1.2% 。 在顯微鏡業務，本集團完成了激光共聚焦掃描 顯微鏡的研發。該顯微鏡的視場大小和成像速 度等均為國內領先水準，且能夠實現高精度掃 描與高速掃描的靈活切換，為科研工作者提供 了更好的硬件支持。同時，在醫療自動化掃描 領域中，本集團於國內首創數值孔徑為 1.4 的 複消色差 60 倍油鏡並實現量產。該物鏡能夠 在保證分辨率的情況下，大幅提升一次成像區 域，提高掃描效率。 在智能裝備業務，本集團完成了病理切片掃描 儀的研發且形成批量銷售，並已經取得國家食 品藥品監督管理總局的認證。該掃描儀採用三 棱鏡顯微光學成像、飛行對焦技術和超景深等 技術，快速形成清晰高色彩還原的病理切片數 字圖像，輔助醫生進行診斷，並對遠程病理和 數字病理存儲提供便利。此外，在工業領域方 面，本集團持續加大研發投入於在線光學檢測 設備，優化設備的效率與性能。 於二零一九年十二月三十一日，本集團在光學 儀器事業中已獲授權專利共 147 項，包括發明 專利 21 項，實用新型專利 100 項及外觀設計專 利 26 項。此外，另有 72 項專利正在申請當中。